240 related articles for article (PubMed ID: 3111844)
1. Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
Lund LR; Riccio A; Andreasen PA; Nielsen LS; Kristensen P; Laiho M; Saksela O; Blasi F; Danø K
EMBO J; 1987 May; 6(5):1281-6. PubMed ID: 3111844
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells.
Keski-Oja J; Raghow R; Sawdey M; Loskutoff DJ; Postlethwaite AE; Kang AH; Moses HL
J Biol Chem; 1988 Mar; 263(7):3111-5. PubMed ID: 3125175
[TBL] [Abstract][Full Text] [Related]
3. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
Sawdey M; Podor TJ; Loskutoff DJ
J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579
[TBL] [Abstract][Full Text] [Related]
4. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta.
Keski-Oja J; Blasi F; Leof EB; Moses HL
J Cell Biol; 1988 Feb; 106(2):451-9. PubMed ID: 3276718
[TBL] [Abstract][Full Text] [Related]
6. Modulation of extracellular proteolytic activity and anchorage-independent growth of cultured cells by sarcoma cell-derived factors: relationships to transforming growth factor-beta.
Laiho M
Exp Cell Res; 1988 Jun; 176(2):297-308. PubMed ID: 3259933
[TBL] [Abstract][Full Text] [Related]
7. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
8. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
Keski-Oja J; Koli K
J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase.
Laiho M; Saksela O; Keski-Oja J
J Biol Chem; 1987 Dec; 262(36):17467-74. PubMed ID: 3121597
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.
Lund LR; Rømer J; Rønne E; Ellis V; Blasi F; Danø K
EMBO J; 1991 Nov; 10(11):3399-407. PubMed ID: 1655420
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
Pepper MS; Belin D; Montesano R; Orci L; Vassalli JD
J Cell Biol; 1990 Aug; 111(2):743-55. PubMed ID: 1696269
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-beta 1.
Koli K; Lohi J; Hautanen A; Keski-Oja J
Eur J Biochem; 1991 Jul; 199(2):337-45. PubMed ID: 1712727
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.
Cheng SL; Shen V; Peck WA
Calcif Tissue Int; 1991 Nov; 49(5):321-7. PubMed ID: 1723649
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor.
Lucore CL; Fujii S; Wun TC; Sobel BE; Billadello JJ
J Biol Chem; 1988 Nov; 263(31):15845-8. PubMed ID: 2846525
[TBL] [Abstract][Full Text] [Related]
16. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta.
Hannocks MJ; Oliver L; Gabrilove JL; Wilson EL
Blood; 1992 Mar; 79(5):1178-84. PubMed ID: 1536945
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
18. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
Jakowlew SB; Mariano JM; You L
Growth Factors; 1997; 14(2-3):177-97. PubMed ID: 9255608
[TBL] [Abstract][Full Text] [Related]
19. The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.
Riccio A; Lund LR; Sartorio R; Lania A; Andreasen PA; Danø K; Blasi F
Nucleic Acids Res; 1988 Apr; 16(7):2805-24. PubMed ID: 3130610
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
